Overview

Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty

Status:
Recruiting
Trial end date:
2022-04-01
Target enrollment:
0
Participant gender:
All
Summary
This will be a prospective assessment of whether adjuvant Netarsudil use in patients undergoing Descemetorhexis without endothelial keratoplasty improves time to corneal clearance and post-operative central endothelial cell counts. The anticipated enrollment is 25 patients.
Phase:
Early Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Criteria
Inclusion Criteria:

- Fuchs corneal dystrophy

Exclusion Criteria:

- Women of childbearing potential

- Other corneal eye diseases

- Non-compliance with netarsudil

- Intolerance of netarsudil